Axa’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-23,200
Closed -$141K 1378
2020
Q3
$141K Sell
23,200
-5,400
-19% -$41.2K ﹤0.01% 1172
2020
Q2
$254K Buy
28,600
+8,700
+44% +$75K ﹤0.01% 1152
2020
Q1
$144K Sell
19,900
-5,000
-20% -$37.1K ﹤0.01% 1126
2019
Q4
$220K Hold
24,900
﹤0.01% 1116
2019
Q3
$152K Sell
24,900
-107,800
-81% -$606K ﹤0.01% 1263
2019
Q2
$555K Sell
132,700
-40,500
-23% -$214K ﹤0.01% 1073
2019
Q1
$1.09M Sell
173,200
-14,000
-7% -$98.1K ﹤0.01% 963
2018
Q4
$1.21M Sell
187,200
-8,400
-4% -$64.2K 0.01% 936
2018
Q3
$1.62M Buy
195,600
+171,300
+705% +$1.3M 0.01% 921
2018
Q2
$151K Buy
+24,300
New +$155K ﹤0.01% 1320
2017
Q2
Sell
-56,600
Closed -$510K 1319
2017
Q1
$510K Sell
56,600
-47,200
-45% -$492K ﹤0.01% 1074
2016
Q4
$1.12M Buy
103,800
+55,097
+113% +$735K 0.01% 881
2016
Q3
$796K Sell
48,703
-57,397
-54% -$808K ﹤0.01% 928
2016
Q2
$1.01M Buy
+106,100
New +$1.15M ﹤0.01% 867
2016
Q1
Sell
-11,800
Closed -$128K 1449
2015
Q4
$128K Hold
11,800
﹤0.01% 1219
2015
Q3
$80K Buy
+11,800
New +$91.3K ﹤0.01% 1322

Other funds holding NPTN

Axa's NPTN Position: Q4 2020 in Review

Axa sold out of NEOPHOTONICS CORP (NPTN) in Q4 2020, closing a stake of 23,200 shares — an estimated $141K sold.

Axa first reported a position in NPTN in Q3 2015 and held it in 16 quarters. The position peaked at $1.62M in Q3 2018. 138 funds tracked by Wall St. Rank hold NPTN as of Q4 2020.

  • Axa reported no remaining NEOPHOTONICS CORP position as of Q4 2020 after selling out during the quarter.
  • Axa sold 23,200 NEOPHOTONICS CORP shares in Q4 2020, an estimated $141K.
  • Axa first reported a position in NEOPHOTONICS CORP in Q3 2015 and held it in 16 quarters.
  • Axa's NEOPHOTONICS CORP position peaked at $1.62M in Q3 2018.
  • 138 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2020.

Based on Axa's 13F filing for Q4 2020, filed 12 Feb 2021.